+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
ID06040203

Randomized Trial Comparing Leukocyte-rich and Leukocyte-poor Platelet Rich Plasma Injections Versus Placebo for Treating Tennis Elbow

Led by Istituto Ortopedico Rizzoli · Updated on 2025-09-29

240

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to assess the clinical outcomes of echo-guided injections using platelet-rich plasma PRP with different leukocyte levels compared to saline injections for treating patients with elbow epicondylitis who have not improved with conservative therapy. The study is a double-blind, randomized controlled trial designed to evaluate the effectiveness and safety of these injection procedures by tracking improvements and any adverse events after treatment. Participants will be randomly assigned to one of three groups a single injection of leukocyte-rich PRP, leukocyte-poor PRP, or a saline placebo injection, all guided by ultrasound to the affected elbow area. Before treatment, blood will be drawn to prepare the autologous PRP, with leukocytes filtered out for the leukocyte-poor group. Patients in the saline group may receive PRP treatment after six months if needed. Each participant will receive one injection and may have access to a second injection if no benefit is observed after six months. Participants will be evaluated before treatment and at 1, 3, 6, and 12 months after injection through clinical examinations and questionnaires. Assessments include various patient-rated scores measuring pain, disability, activity level, and overall health. Adverse events, swelling, pain duration, and any medications taken will be recorded throughout follow-up visits. The primary outcome measure is the Patient-rated Tennis Elbow Evaluation at six months, with several secondary assessments conducted at multiple time points.

CONDITIONS

Brief Title

Leukocyte-rich PRP or Leukocyte-free PRP vs Placebo in the Treatment of Epicondylitis

Research Team

E

Enrico Guerra, MD

R

Roberta Licciardi, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here